Andrea Casazza
Andrea Casazza
Director Biology @ Montis Bioscience, Belgium
Email verificata su - Home page
Citata da
Citata da
Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity
A Casazza, D Laoui, M Wenes, S Rizzolio, N Bassani, M Mambretti, ...
Cancer cell 24 (6), 695-709, 2013
MET is required for the recruitment of anti-tumoural neutrophils
V Finisguerra, G Di Conza, M Di Matteo, J Serneels, S Costa, ...
Nature 522 (7556), 349-353, 2015
Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment
A Casazza, G Di Conza, M Wenes, V Finisguerra, S Deschoemaeker, ...
Oncogene 33 (14), 1743-1754, 2014
miR-511-3p Modulates Genetic Programs of Tumor-Associated Macrophages
ML Squadrito, F Pucci, L Magri, D Moi, GD Gilfillan, A Ranghetti, ...
Cell Reports, 2012
Sema3E–Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice
A Casazza, V Finisguerra, L Capparuccia, A Camperi, JM Swiercz, ...
The Journal of clinical investigation 120 (8), 2684-2698, 2010
Systemic and targeted delivery of semaphorin 3A inhibits tumor angiogenesis and progression in mouse tumor models
A Casazza, X Fu, I Johansson, L Capparuccia, F Andersson, ...
Arteriosclerosis, thrombosis, and vascular biology 31 (4), 741-749, 2011
Plexin signaling hampers integrin-based adhesion, leading to Rho-kinase independent cell rounding, and inhibiting lamellipodia extension and cell motility
D Barberis, S Artigiani, A Casazza, S Corso, S Giordano, CA Love, ...
The FASEB journal 18 (3), 592-594, 2004
p190 Rho-GTPase activating protein associates with plexins and it is required for semaphorin signalling
D Barberis, A Casazza, R Sordella, S Corso, S Artigiani, J Settleman, ...
Journal of cell science 118 (20), 4689-4700, 2005
The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironment
C Rolny, L Capparuccia, A Casazza, M Mazzone, A Vallario, A Cignetti, ...
The Journal of experimental medicine 205 (5), 1155-1171, 2008
Tumour growth inhibition and anti‐metastatic activity of a mutated furin‐resistant Semaphorin 3E isoform
A Casazza, B Kigel, F Maione, L Capparuccia, O Kessler, E Giraudo, ...
EMBO molecular medicine, 2012
Cross‐talk between vascular endothelial growth factor and semaphorin‐3A pathway in the regulation of normal and malignant mesothelial cell proliferation
A Catalan, P Caprari, S Rodilossi, P Betta, M Castellucci, A Casazza, ...
The FASEB journal 18 (2), 1-20, 2004
Semaphorin signals in cell adhesion and cell migration: functional role and molecular mechanisms
A Casazza, P Fazzari, L Tamagnone
Semaphorins: Receptor and Intracellular Signaling Mechanisms, 90-108, 2007
Secreted CLIC3 drives cancer progression through its glutathione-dependent oxidoreductase activity
Nature Communication 8 (14206), 2017
Identification of a chronic non‐neurodegenerative microglia activation state in a mouse model of peroxisomal β‐oxidation deficiency
S Verheijden, L Beckers, A Casazza, O Butovsky, M Mazzone, M Baes
Glia 63 (9), 1606-1620, 2015
In Vivo Antitumoral Efficacy of PhAc-ALGP-Doxorubicin, an Enzyme-Activated Doxorubicin Prodrug, in Patient-Derived Soft Tissue Sarcoma Xenograft ModelsPhAc-ALGP-Doxorubicin in…
J Cornillie, A Wozniak, P Pokreisz, A Casazza, L Vreys, J Wellens, ...
Molecular Cancer Therapeutics 16 (8), 1566-1575, 2017
Altering the intratumoral localization of macrophages to inhibit cancer progression
A Casazza, M Mazzone
Oncoimmunology 3 (3), e27872, 2014
Sustained placental growth factor-2 treatment does not aggravate advanced atherosclerosis in ischemic cardiomyopathy
M Wu, P Pokreisz, M Swinnen, E Caluwe, H Gillijns, N Vanden Driessche, ...
Journal of Cardiovascular Translational Research 10 (4), 348-358, 2017
PhAc-ALGP-Dox, a novel anticancer prodrug with targeted activation and improved therapeutic index
A Casazza, L Van Helleputte, B Van Renterghem, P Pokreisz, N De Geest, ...
Molecular Cancer Therapeutics 21 (4), 568-581, 2022
Enhanced antitumor efficacy of PhAc-ALGP-Dox, an enzyme-activated doxorubicin prodrug, in a panel of THOP1-expressing patient-derived xenografts of soft tissue sarcoma
B Van Renterghem, A Wozniak, L Tarantola, A Casazza, J Wellens, ...
Biomedicines 10 (4), 862, 2022
Sema3E–Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice
A Casazza, V Finisguerra, L Capparuccia, A Camperi, JM Swiercz, ...
The Journal of Clinical Investigation 121 (7), 2945-2945, 2011
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20